Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease

References

• Boutari C, Mantzoros CS. 2020. Adiponectin and leptin in the diagnosis and therapy of NAFLD. Metabolism. 103:154028.
   PubMed Web of Science ®Google Scholar
• Braud L, Battault S, Meyer G, Nascimento A, Gaillard S, Sousa G, Rahmani R, Riva C, Armand M, Maixent JM, et al. 2017. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model. J Nutr Biochem. 40:95–104.
   PubMed Web of Science ®Google Scholar
• Chen S, Wu Z, Ke Y, Shu P, Chen C, Lin R, Shi Q. 2019. Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis. Acta Biochim Biophys Sin (Shanghai). 51(11):1096–1105.
   PubMed Web of Science ®Google Scholar
• Danford CJ, Lai M. 2019. NAFLD: a multisystem disease that requires a multidisciplinary approach. Frontline Gastroenterol. 10(4):328–329.
   PubMed Web of Science ®Google Scholar
• Deng Y, Tang K, Chen R, Liu Y, Nie H, Wang H, Zhang Y, Yang Q. 2018. Effects of Shugan-jianpi recipe on the expression of the p38 MAPK/NF-κB signaling pathway in the hepatocytes of NAFLD rats. Medicines (Basel). 5(3):106.
   PubMedGoogle Scholar
• El-Din SH, Sabra AN, Hammam OA, Ebeid FA, El-Lakkany NM. 2014. Pharmacological and antioxidant actions of garlic and or onion in non-alcoholic fatty liver disease (NAFLD) in rats. J Egypt Soc Parasitol. 44(2):295–308.
   PubMedGoogle Scholar
• Ezquerro S, Mocha F, Frühbeck G, Guzmán-Ruiz R, Valentí V, Mugueta C, Becerril S, Catalán V, Gómez-Ambrosi J, Silva C, et al. 2019. Ghrelin reduces TNF-α-induced human hepatocyte apoptosis, autophagy, and pyroptosis: role in obesity-associated NAFLD. J Clin Endocrinol Metab. 104(1):21–37.
   PubMed Web of Science ®Google Scholar
• Fan H, Ma X, Lin P, Kang Q, Zhao Z, Wang L, Sun D, Cheng J, Li Y. 2017. Scutellarin prevents nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia via PI3K/AKT-dependent activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in rats. Med Sci Monit. 23:5599–5612.
   PubMed Web of Science ®Google Scholar
• Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. 2019. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 19(7):994–1003.
   PubMed Web of Science ®Google Scholar
• Feng X, Yu W, Li X, Zhou F, Zhang W, Shen Q, Li J, Zhang C, Shen P. 2017. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochem Pharmacol. 136:136–149.
   PubMed Web of Science ®Google Scholar
• Gao YZ, Zhao LF, Ma J, Xue WH, Zhao H. 2016. Protective mechanisms of wogonoside against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Eur J Pharmacol. 780:8–15.
   PubMed Web of Science ®Google Scholar
• Kashyap ML, Ganji S, Nakra NK, Kamanna VS. 2019. Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug? J Clin Lipidol. 13(6):873–879.
   PubMed Web of Science ®Google Scholar
• Kobyliak N, Abenavoli L, Falalyeyeva T, Virchenko O, Natalia B, Beregova T, Bodnar P, Spivak M. 2016. Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles. Clujul Med. 89(2):229–235.
   PubMedGoogle Scholar
• Ku SK, Bae JS. 2014. Antithrombotic activities of wogonin and wogonoside via inhibiting platelet aggregation. Fitoterapia. 98:27–35.
   PubMed Web of Science ®Google Scholar
• Liang S, Zhang Y, Deng Y, He Y, Liang Y, Liang Z, Chen Y, Tang K, Chen R, Yang Q. 2018. The potential effect of Chinese herbal formula Hongqijiangzhi fang in improving NAFLD: focusing on NLRP3 inflammasome and gut microbiota. Evid Based Complement Alternat Med. 2018:5378961.
   PubMed Web of Science ®Google Scholar
• Niu T, Xuan R, Jiang L, Wu W, Zhen Z, Song Y, Hong L, Zheng K, Zhang J, Xu Q, et al. 2018. Astaxanthin induces the Nrf2/HO-1 antioxidant pathway in human umbilical vein endothelial cells by generating trace amounts of ROS. J Agric Food Chem. 66(6):1551–1559.
   PubMed Web of Science ®Google Scholar
• Oliveira S, Houseright RA, Graves AL, Golenberg N, Korte BG, Miskolci V, Huttenlocher A. 2019. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish. J Hepatol. 70(4):710–721.
   PubMed Web of Science ®Google Scholar
• Pan ZG, An XS. 2018. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. Biochem Biophys Res Commun. 498(3):416–423.
   PubMed Web of Science ®Google Scholar
• Sindhu S, Kochumon S, Shenouda S, Wilson A, Al-Mulla F, Ahmad R. 2019. The cooperative induction of CCl4 in human monocytic cells by TNF-α and palmitate requires MyD88 and involves MAPK/NF-κB signaling pathways. Int J Mol Sci. 20:E4658.
   PubMed Web of Science ®Google Scholar
• Świderska M, Maciejczyk M, Zalewska A, Pogorzelska J, Flisiak R, Chabowski A. 2019. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients. Free Radic Res. 53(8):841–850.
   PubMed Web of Science ®Google Scholar
• Tang Q, Zheng G, Feng Z, Tong M, Xu J, Hu Z, Shang P, Chen Y, Wang C, Lou Y, et al. 2017. Wogonoside inhibits IL-1β induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis. Oncotarget. 8(37):61440–61456.
   PubMedGoogle Scholar
• Wang Q, Wen R, Lin Q, Wang N, Lu P, Zhu X. 2015. Wogonoside shows antifibrotic effects in an experimental regression model of hepatic fibrosis. Dig Dis Sci. 60(11):3329–3339.
   PubMed Web of Science ®Google Scholar
• Wu W, Peng G, Yang F, Zhang Y, Mu Z, Han X. 2019. Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO-1 axis. Mol Med Rep. 20:1761–1771.
   PubMed Web of Science ®Google Scholar
• Xu J, Li C, Li Z, Yang C, Lei L, Ren W, Su Y, Chen C. 2018. Protective effects of oxymatrine against lipopolysaccharide/d-galactosamine-induced acute liver failure through oxidative damage, via activation of Nrf2/HO-1 and modulation of inflammatory TLR4-signaling pathways. Mol Med Rep. 17(1):1907–1912.
   PubMed Web of Science ®Google Scholar
• Yan C, Zhang Y, Zhang X, Aa J, Wang G, Xie Y. 2018. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. Biomed Pharmacother. 105:274–281.
   PubMed Web of Science ®Google Scholar
• Yan Y, Yao L, Sun H, Pang S, Kong X, Zhao S, Xu S. 2020. Effects of wogonoside on invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors of nude mice. J Thorac Dis. 12(4):1552–1560.
   PubMed Web of Science ®Google Scholar
• Yang DK, Jo DG. 2018. Mulberry fruit extract ameliorates nonalcoholic fatty liver disease (NAFLD) through inhibition of mitochondrial oxidative stress in rats. Evid Based Complement Alternat Med. 2018:8165716.
   PubMed Web of Science ®Google Scholar
• Zeng C, Zhong P, Zhao Y, Kanchana K, Zhang Y, Khan ZA, Chakrabarti S, Wu L, Wang J, Liang G. 2015. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. J Mol Cell Cardiol. 79:1–12.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren Y, Yang C, Guo Y, Zhang X, Hou G, Guo X, Sun N, Liu Y. 2014. Wogonoside ameliorates lipopolysaccharide-induced acute lung injury in mice. Inflammation. 37(6):2006–2012.
   PubMed Web of Science ®Google Scholar
• Zhang P, Yin Y, Wang T, Li W, Li C, Zeng X, Yang W, Zhang R, Tang Y, Shi L, et al. 2020. Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling. Free Radic Biol Med. 147:23–36.
   PubMed Web of Science ®Google Scholar
• Zhu SL, Wu QH, Tu J. 2019. Study on regulation of NLRP3/SOCS3-TLR4-NF-κB inflammatory pathway by wogonoside to improve hepatic insulin resistance. Zhongguo Zhong Yao Za Zhi. 44:4504–4510.
   PubMedGoogle Scholar